DNA damaging agents in ovarian cancer.

Barretina-Ginesta, Maria-Pilar

Barretina-Ginesta, Maria-Pilar.

Affiliation

Barretina-Ginesta MP; Department of Medical Oncology, Catalan Institute of Oncology (ICO) Girona, Girona Biomedical Research Institute (IDIBGI), Department of Medical Sciences, Medical School University of Girona (UdG), Spain.

EJC Suppl ; 15: 67-72, 2020 Aug.

Article in En | MEDLINE | ID: mdl-33240444

Key words

DNA damaging agents; Ovarian cancer; Parp inhibitors; Platinum

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573464
https://dx.doi.org/10.1016/j.ejcsup.2020.06.001

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJC Suppl Year: 2020 Type: Article Affiliation country: Spain

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573464
https://dx.doi.org/10.1016/j.ejcsup.2020.06.001

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJC Suppl Year: 2020 Type: Article Affiliation country: Spain